Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability
Saleh AlAsiri, … , Michael A. Trakselis, Aleksandar Rajkovic
Saleh AlAsiri, … , Michael A. Trakselis, Aleksandar Rajkovic
Published December 1, 2014
Citation Information: J Clin Invest. 2015;125(1):258-262. https://doi.org/10.1172/JCI78473.
View: Text | PDF
Brief Report Genetics Article has an altmetric score of 30

Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability

  • Text
  • PDF
Abstract

Premature ovarian failure (POF) is a genetically and phenotypically heterogeneous disorder that includes individuals with manifestations ranging from primary amenorrhea to loss of menstrual function prior to age 40. POF presents as hypergonadotropic hypogonadism and can be part of a syndrome or occur in isolation. Here, we studied 3 sisters with primary amenorrhea, hypothyroidism, and hypergonadotropic hypogonadism. The sisters were born to parents who are first cousins. SNP analysis and whole-exome sequencing revealed the presence of a pathogenic variant of the minichromosome maintenance 8 gene (MCM8, c.446C>G; p.P149R) located within a region of homozygosity that was present in the affected daughters but not in their unaffected sisters. Because MCM8 participates in homologous recombination and dsDNA break repair, we tested fibroblasts from the affected sisters for hypersensitivity to chromosomal breaks. Compared with fibroblasts from unaffected daughters, chromosomal break repair was deficient in fibroblasts from the affected individuals, likely due to inhibited recruitment of MCM8 p.P149R to sites of DNA damage. Our study identifies an autosomal recessive disorder caused by an MCM8 mutation that manifests with endocrine dysfunction and genomic instability.

Authors

Saleh AlAsiri, Sulman Basit, Michelle A. Wood-Trageser, Svetlana A. Yatsenko, Elizabeth P. Jeffries, Urvashi Surti, Deborah M. Ketterer, Sibtain Afzal, Khushnooda Ramzan, Muhammad Faiyaz-Ul Haque, Huaiyang Jiang, Michael A. Trakselis, Aleksandar Rajkovic

×

Figure 2

MCM8 mutation impairs DNA break repair.

Options: View larger image (or click on image) Download as PowerPoint
MCM8 mutation impairs DNA break repair.
Cells from homozygous MCM8 c.446...
Cells from homozygous MCM8 c.446C>G individuals have an impaired ability to repair dsDNA breaks induced by MMC. A total of 4 experimental groups were treated with MMC for each sample. Representative metaphase cells treated with 300 nM MMC are shown from (A) a healthy and fertile individual with the MCM8 WT/WT genotype (family member IV-3), (B) an unaffected WT/MT genotype individual (family member III-2), and (C) an affected female homozygous for the MCM8 c.446C>G pathogenic variant (MT/MT genotype; family member IV-1). Arrows point to chromosomal breaks. Original magnification, ×63/1.4 for chromosomal spreads and ×4 for inserts from the spreads. Scale bars: 10 μm. (D) At least 10 metaphase cells were used to calculate the total number of chromosomal breaks per cell for each MMC concentration. The number of chromosomal breaks counted was limited to 60 per cell, and those with more were indicated as 60+ breaks per cell. Error bars represent SEM. *P < 0.01, **P < 0.001, and ***P < 0.0001 by 2-tailed t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 7 X users
Mentioned by 6 weibo users
On 1 Facebook pages
Referenced in 3 Wikipedia pages
106 readers on Mendeley
See more details